ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 97 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,491 | -81.9% | 14,269 | -71.7% | 0.00% | -80.0% |
| Q2 2023 | $378,737 | +93.7% | 50,431 | +16.6% | 0.01% | +100.0% |
| Q1 2023 | $195,576 | +3.6% | 43,269 | +158.3% | 0.01% | 0.0% |
| Q4 2022 | $188,761 | +4.9% | 16,749 | -24.6% | 0.01% | -37.5% |
| Q2 2022 | $180,000 | -70.8% | 22,211 | -22.6% | 0.01% | -78.9% |
| Q4 2021 | $616,000 | +145.4% | 28,678 | +744.0% | 0.04% | +90.0% |
| Q3 2021 | $251,000 | +8.2% | 3,398 | -19.9% | 0.02% | 0.0% |
| Q2 2021 | $232,000 | – | 4,241 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $46,559,640 | 13.20% |
| Vivo Capital, LLC | 4,220,048 | $20,256,230 | 2.22% |
| Logos Global Management LP | 1,000,000 | $4,800,000 | 0.64% |
| Orbimed Advisors | 2,871,000 | $13,780,800 | 0.29% |
| Redmile Group, LLC | 1,283,289 | $6,159,787 | 0.29% |
| BRAIDWELL LP | 1,249,900 | $5,999,520 | 0.19% |
| Cormorant Asset Management, LP | 612,079 | $2,937,979 | 0.17% |
| Nan Fung Group Holdings Ltd | 41,950 | $201,360 | 0.16% |
| Forefront Analytics, LLC | 13,769 | $66,092 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 35,071 | $168,341 | 0.03% |